Next Science signs deal to sell majority of assets for $50 million
SYDNEY: Next Science Limited (ASX:NXS), an Australian medical technology company, announced Tuesday it has entered into a binding agreement to sell the majority of its assets to Italy-based Demetra Holdings S.p.A. for $50 million. The deal includes the sale of regulatory approvals, intellectual property, inventory, and other assets but excludes Next Science’s diabetic foot infection…